Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Akom Pharmaceuticals, Inc.
EIR
•Akom Pharmaceuticals, Inc.•September 17, 2010

Akom Pharmaceuticals, Inc. – FDA EIR, Sep 17, 2010

Record Details

Akorn, Inc. underwent an FDA compliance inspection at its Decatur, IL facility from August 25 to September 17, 2010. Conducted under regulatory frameworks for drug manufacturing, including sterile and animal drug production, this follow-up inspection assessed various quality systems. While the firm addressed many deficiencies from a prior 2009 inspection, the 2010 review identified eight new and continuing issues. Key violations included failing to reject drug products that did not meet established specifications, such as exceeding validated light exposure or hold times, and subsequently distributing these products. The company also used expired raw materials in manufacturing and released products without adequate stability data to support expiration dating. Further deficiencies involved insufficient investigation of failed batches, releasing products before complete testing, and failures in following and maintaining comprehensive written procedures for production and control. Akorn's management acknowledged the observations and committed to providing a response detailing corrective actions within 15 days.

Company
Akom Pharmaceuticals, Inc.
Inspection date
September 17, 2010
Product type
Drugs
Office
Chicago District Office
People
  • Phung Thien Nguyen (Investigator )
  • CDR Carl A. Huffman III
  • Kimberly J. Wasserkrug (recipient)
View Company Profile

ID · 9413489d-6742-410b-9cac-eca8e5e86b5c

Violation Codes10
21 CFR 211.100(b)21 CFR 211.84(a)21 CFR 211.11121 CFR 211.1121 CFR 211.165(f)21 CFR 211.137(a)21 CFR 211.19221 CFR 211.80(a)21 CFR 820.5021 CFR 211.186(b)(9)

Full citation text and observation details available on the Dashboard.

Other documents for Akom Pharmaceuticals, Inc.
  • 483 - 2022-04-08April 8, 2022
  • 483 - 2018-05-16May 16, 2018
  • 483 - 2018-04-09April 9, 2018
  • 483 - 2017-04-26April 26, 2017
  • 483 - 2016-06-10June 10, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Akom Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.